Start for free
Start for free
Highline Capital Management logo

Highline Capital Management

North America, New York, United States, New York

Description

Highline Capital Management is an investment firm that focuses on mid and large capitalization U.S. equities long and short.

Investor Profile

Highline Capital Management has made 8 investments, with 1 in the past 12 months and 13% as lead.

Stage Focus

  • Series C (38%)
  • Series B (25%)
  • Seed (13%)
  • Series D (13%)
  • Series A (13%)

Country Focus

  • United States (88%)
  • Germany (13%)

Industry Focus

  • Biotechnology
  • Life Science
  • Medical
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Bioinformatics
  • Biopharma
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Highline Capital Management frequently co-invest with?

Razor's Edge Ventures
Razor's Edge Ventures
North America, Virginia, United States, Reston
Co-Investments: 2
Alpha Intelligence Capital
Alpha Intelligence Capital
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 2
Emerald Development Managers
Emerald Development Managers
North America, New York, United States, New York
Co-Investments: 2
Thiel Capital
Thiel Capital
North America, California, United States, Los Angeles
Co-Investments: 2
ROBO Global
ROBO Global
North America, Texas, United States, Dallas
Co-Investments: 2
Scale Venture Partners
Scale Venture Partners
North America, California, United States, Foster City
Co-Investments: 2
Robin Hood Ventures
Robin Hood Ventures
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
Logos Capital
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 2
Triangle Peak Partners
Triangle Peak Partners
North America, California, United States, Palo Alto
Co-Investments: 2
Hitachi Ventures
Hitachi Ventures
Europe, Bayern, Germany, München
Co-Investments: 2

Which angels does Highline Capital Management often collaborate with?

SK
Suzanne Kayne
North America, California, United States, Los Angeles
Shared Deals: 1
RK
Richard Kayne
North America, California, United States, Los Angeles
Shared Deals: 1
KT
Kenan Turnacioglu
North America, New York, United States, New York
Shared Deals: 1
AK
Arda Kara
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Highline Capital Management?

Network Bio

New York, New York, United States

Network Bio's biomedical data for AI-enabled precision medicine

BioinformaticsBiopharmaLife ScienceMedicalPrecision Medicine
SeedFeb 27, 2025
Amount Raised: $17,000,000
Proscia

Philadelphia, Pennsylvania, United States

Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical
Series CJan 11, 2024
Amount Raised: $9,000,000
Proscia

Philadelphia, Pennsylvania, United States

Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical
Series CJun 3, 2022
Amount Raised: $36,617,270
Strata Oncology

Ann Arbor, Michigan, United States

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

BiotechnologyGeneticsHealth CareHealth DiagnosticsMedical DeviceOncology
Series CJul 28, 2021
Amount Raised: $90,000,000
ATAI Life Sciences

Munich, Bayern, Germany

ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.

BiotechnologyHealth CareLife ScienceMental HealthTherapeutics
Series DMar 3, 2021
Amount Raised: $157,000,000
Longboard Pharmaceuticals

San Diego, California, United States

Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series AOct 28, 2020
Amount Raised: $56,000,000
Athira Pharma

Seattle, Washington, United States

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

BiotechnologyPharmaceuticalTherapeutics
Series BJun 4, 2020
Amount Raised: $85,000,000
Passage Bio

Philadelphia, Pennsylvania, United States

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series BSep 4, 2019
Amount Raised: $110,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator